Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Nov 19;37(4):302-304.
doi: 10.4274/tjh.galenos.2020.2020.0322. Epub 2020 Jul 23.

Hydroxychloroquine-Associated Thrombotic Thrombocytopenic Purpura

Fatma Arıkan  1 , Yasin Yıldız  2 , Tarık Ercan  1 , Özen Oruç  1 , Seçkin Akçay  3 , Fergun Yılmaz  1 , Tayfur Toptaş  1 , Tülin Tuğlular  1
Affiliations
Case Reports

Hydroxychloroquine-Associated Thrombotic Thrombocytopenic Purpura

Fatma Arıkan et al. Turk J Haematol. .
No abstract available

Keywords: Hydroxychloroquine; Severe acute respiratory syndrome-related coronavirus; Thrombotic thrombocytopenic purpura.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: We confirm that there are no conflicts of interest to declare.

Comment in

References

    1. Bendapudi PK, Hurwitz S, Fry A, Marques MB, Waldo SW, Li A, Sun L, Upadhyay V, Hamdan A, Brunner AM, Gansner JM, Viswanathan S, Kaufman RM, Uhl L, Stowell CP, Dzik WH, Makar RS. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol. 2017;4:e157–e164. - PubMed
    1. George JN. How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood. 2010;116:4060–4069. - PubMed
    1. Fromm LM. Suspected hydroxychloroquine-induced thrombotic thrombocytopaenic purpura. J Pharm Pract Res. 2018;48:72–75.
    1. Mar N, Mendoza Ladd A. Acquired thrombotic thrombocytopenic purpura: puzzles, curiosities and conundrums. J Thromb Thrombolysis. 2011;31:119–121. - PubMed
    1. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–245. - PubMed

MeSH terms